feed,title,long_url,short_url
SeekingAlpha,Sanofi Sarclisa combo gains approval as first-line multiple myeloma treatment,https://seekingalpha.com/news/4151719,
SeekingAlpha,Midland Capital acquired by investor group for $31.65 per share,https://seekingalpha.com/news/4151720,
